Peter Valent. 2011. “On the Safety of Low-Dose Dasatinib in Comorbid and Non-Comorbid Patients: What Is Real-Life? (Reply)”. Haematologica 96 (4). Pavia, Italy, e25-e25. https://doi.org/10.3324/haematol.2011.041608.